Who owns Exeliom Biosciences?

Exeliom Biosciences is currently owned by Capital Grand Est, through Cap Innov'Est 1, since 2017.

When did Capital Grand Est acquire Exeliom Biosciences?

Capital Grand Est acquired Exeliom Biosciences in 2017 (active for 9 years).

Home/Companies/Healthcare/Exeliom Biosciences

Exeliom Biosciences

Healthcare·

France·Active·9yr hold

Exeliom Biosciences is a healthcare company, headquartered in France.

Entry

2017

Hold

9yr

Status

Active

Est. EV

–

Investor

Capital Grand Est

Key facts

HQFrance

SectorHealthcare

Exeliom Biosciences develops a monoclonal bacterial strain for treating chronic intestinal inflammatory diseases.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Cap Innov'Est 1

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings